Home › Core › ISCC-IDs › 28CrZJVKoY6qb

View ISCC-ID

Core Data

28CrZJVKoY6qb
ISCC-ID - digital asset identifier
CCcAmTNgPAbC6-CTrQ1DevjDGvc-CDebFqUqwpsWK-CRThFY7R1bq26
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

major molecular response induced by nilotinib as first line treatment in a lmc patient with intermediate sokal risk

Ledger Reference

coblo
Source Ledger/Blockchain
355392
N-th ISCC Decleration on source ledger
6fabadb9b03632cfe835cd4d54593e45a9242f049350613ea16b512a1974e1ec
Hash of block that includes the ISCC-DECLARATION
bf78c3cfefd055ccb33f2a119f522528af401edffde1b532bd479ab46f49a29c
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Major molecular response induced by nilotinib as first line treatment in a LMC patient with intermediate Sokal risk", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Ursula Sessa", "@type": "Person"}, {"name": "Maria Celentano", "@type": "Person"}, {"name": "Stefano Rocco", "@type": "Person"}, {"name": "Rossella Fabbricini", "@type": "Person"}, {"name": "Olimpia Finizio", "@type": "Person"}, {"name": "Vincenzo Mettivier", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://journals.seedmedicalpublishers.com/index.php/cmi/article/download/1138/1349", "encodingFormat": "application/pdf"}], "publisher": {"name": "Seed SRL", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.7175/cmi.v6i2s.1138", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCcAmTNgPAbC6-CTrQ1DevjDGvc-CDebFqUqwpsWK-CRThFY7R1bq26", "propertyID": "ISCC"}], "datePublished": "2015-10-13"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close